Seeing Is Believing
Healthcare - Sector
Marker Therapeutics's activity chart (see below) currently has 19 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 2.08% with an average time for these price targets to be met of 0.88 days.
Most recent stock forecast was given by from BROOKLINE on 10-Feb-2025. First documented stock forecast 22-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Feb-2025
$4
$2.68 (203.03%)
1 years 8 months ago
(10-Feb-2025)
0/1 (0%)
$2.28 (132.56%)
Buy Since 30-Apr-2024
$11
$9.68 (733.33%)
$11
1 years 11 months 19 days ago
(21-Oct-2024)
0/2 (0%)
$7.3 (197.30%)
Buy Since 25-Mar-2021
$40
4 years 4 months 13 days ago
(27-May-2022)
0/2 (0%)
$35.43 (775.27%)
Buy Since 03-Jul-2019
$80
4 years 7 months 23 days ago
(17-Feb-2022)
0/2 (0%)
$62.7 (362.43%)
Buy Since 11-Feb-2020
$10
$8.95 (852.38%)
$60
4 years 7 months 23 days ago
(17-Feb-2022)
0/5 (0%)
$5.4 (117.39%)
What is MRKR (Marker Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on MRKR (Marker Therapeutics)?
Which analyst has the current lower performing score on MRKR (Marker Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MRKR (Marker Therapeutics)?
Which analyst is the currently most bullish on MRKR (Marker Therapeutics)?
Which analyst is the currently most reserved on MRKR (Marker Therapeutics)?